Mini review: Current molecular methods for the detection and quantification of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1

International Journal of Infectious Diseases

Volumn 25, Issue , 2014, Pages 145-149

  Albertoni, Guilherme ^a,b   Castelo Girão, Manoel João Batista ^b   Schor, Nestor ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Laboratório de Espectrometria de Massas Associação Beneficente de Coleta de Sangue   (Brazil)

Author keywords

HBV; HCV; HIV; NAT testing

Indexed keywords

NUCLEIC ACID;

ANALYTIC METHOD; ANALYTICAL PARAMETERS; BLOOD DONOR; CHEMICAL REACTION; CLINICAL EVALUATION; COBAS TAQSCREEN MPX TEST; COMPARATIVE STUDY; GENE AMPLIFICATION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LIMIT OF DETECTION; MASS SCREENING; NUCLEIC ACID AMPLIFICATION; NUCLEIC ACID ANALYSIS; REACTION ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; TIGRIS SYSTEM; VIRUS DETECTION; VIRUS DIAGNOSIS; VIRUS INFECTIVITY; WEST NILE FLAVIVIRUS; WORLD HEALTH ORGANIZATION; GENETICS; HEPACIVIRUS; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; MOLECULAR DIAGNOSIS; POLYMERASE CHAIN REACTION; PROCEDURES; STANDARDS; VIROLOGY;

HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; POLYMERASE CHAIN REACTION;

EID: 84903488492     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.04.007     Document Type: Review

References (47)

1. Tabor E., Epstein J.S. NAT screening of blood and plasma donations: evolution of technology and regulatory policy. Transfusion 2002, 42:1230-1237.
2. Lau L.T., Feng X.Y., Lam T.Y., Hui H.K., Yu A.C. Development of multiplex nucleic acid sequence-based amplification for detection of human respiratory tract viruses. J Virol Methods 2010, 168:251-254.
3. Templeton K.E., Scheltinga S.A., Beersma M.F., Kroes A.C., Claas E.C. Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza A and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3, and 4. J Clin Microbiol 2004, 42:1564-1569.
4. Grabarczyk P., van Drimmelen H., Kopacz A., Gdowska J., Liszewski G., Piotrowski D., et al. Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1 in blood donors. Transfusion 2013, 53:2512-2524.
5. Stramer S.L., Glynn S.A., Kleinman S.H., Strong D.M., Caglioti S., Wright D.J., et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004, 351:760-768.
6. Laperche S. Blood safety and nucleic acid testing in Europe. Euro Surveill 2005, 10:3-4.
7. Roth W.K., Busch M.P., Schuller A., Ismay S., Cheng A., Seed C.R., et al. International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang 2012, 102:82-90.
8. Levi J.E., Pereira R.A., Polite M.B., Mota M.A., Nunez S.P., Pinho J.R., et al. One window-period donation in two years of individual donor-nucleic acid test screening for hepatitis B, hepatitis C and human immunodeficiency virus. Rev Bras Hematol Hemoter 2013, 35:167-170.
9. LaBarre P., Hawkins K.R., Gerlach J., Wilmoth J., Beddoe A., Singleton J., et al. A simple, inexpensive device for nucleic acid amplification without electricity-toward instrument-free molecular diagnostics in low-resource settings. PLoS One 2011, 6:e19738.
10. Mabey D., Peeling R.W., Ustianowski A., Perkins M.D. Diagnostics for the developing world. Nat Rev Microbiol 2004, 2:231-240.
11. Ngom B., Guo Y., Wang X., Bi D. Development and application of lateral flow test strip technology for detection of infectious agents and chemical contaminants: a review. Anal Bioanal Chem 2010, 397:1113-1135.
12. Peeling R.W., Mabey D., Herring A., Hook E.W. Why do we need quality-assured diagnostic tests for sexually transmitted infections?. Nat Rev Microbiol 2006, 4:S7-S19.
13. Tucker J.D., Bu J., Brown L.B., Yin Y.P., Chen X.S., Cohen M.S. Accelerating worldwide syphilis screening through rapid testing: a systematic review. Lancet Infect Dis 2010, 10:381-386.
14. Frégeau C.J., Lett C.M., Elliott J., Yensen C., Fourney R.M. Automated processing of forensic casework samples using robotic workstations equipped with nondisposable tips: contamination prevention. J Forensic Sci 2008, 53:632-651.
15. Kamal S.M. Acute hepatitis C: a systematic review. Am J Gastroenterol 2008, 103:1283-1297.
16. Chevaliez S., Pawlotsky J.M. Practical use of hepatitis C virus kinetics monitoring in the treatment of chronic hepatitis C. J Viral Hepat 2007, 1:77-81.
17. Albertoni G., Arnoni C.P., Araújo P.R., Carvalho F.O., Barreto J.A. Signal to cut-off (S/CO) ratio and detection of HCV genotype 1 by real-time PCR one-step method: is there any direct relationship?. Braz J Infect Dis 2010, 14:147-152.
18. Wendel S., Levi J.E., Takaoka D.T., Silva I.C., Castro J.P., Torezan-Filho M.A., et al. Primary screening of blood donors by NAT testing for HCV-RNA: development of an "in-house" method and results. Rev Inst Med Trop Sao Paulo 2007, 49:177-185.
19. Paryan M., Forouzandeh M.M., Kia V., Mohammadi-Yeganeh S., Abbasali R.A., Mirab S.S. Design and development of an in-house multiplex RT-PCR assay for simultaneous detection of HIV-1 and HCV in plasma samples. Iran J Microbiol 2012, 4:8-14.
20. Albertoni G.A., Arnoni C.P., Araujo P.R., Andrade S.S., Carvalho F.O., Girão M.J., et al. Magnetic bead technology for viral RNA extraction from serum in blood bank screening. Braz J Infect Dis 2011, 15:547-552.
21. Glaubitz J., Sizmann D., Simon C.O., Hoffmann K.S., Drogan D., Hesse M., et al. Accuracy to 2nd International HIV-1 RNA WHO Standard: assessment of three generations of quantitative HIV-1 RNA nucleic acid amplification tests. J Clin Virol 2011, 50:119-124.
22. De Crignis E., Re M.C., Cimatti L., Zecchi L., Gibellini D. HIV-1 and HCV detection in dried blood spots by SYBR Green multiplex real-time RT-PCR. J Virol Methods 2010, 165:51-56.
23. Oliveira dos Santos A., Souza L.F., Borzacov L.M., Villalobos-Salcedo J.M., Vieira D.S. Development of cost-effective real-time PCR test: to detect a wide range of HBV DNA concentrations in the western Amazon region of Brazil. Virol J 2014, 11:16.
24. Yalamanchili N., Syed R., Chandra M., Satti V., Rao R., Mohammed A.H., et al. A latest and promising approach for prediction of viral load in hepatitis B virus infected patients. Indian J Hum Genet 2011, 17:17-21.
25. Takizawa K., Nakashima T., Mizukami T., Kuramitsu M., Endoh D., Kawauchi S., et al. Degenerate polymerase chain reaction strategy with DNA microarray for detection of multiple and various subtypes of virus during blood screening. Transfusion 2013, 53:2545-2555.
26. Müller M.M., Fraile M.I., Hourfar M.K., Peris L.B., Sireis W., Rubin M.G., et al. Evaluation of two commercial, multi-dye, nucleic acid amplification technology tests, for HBV/HCV/HIV-1/HIV-2 and B19V/HAV, for screening blood and plasma for further manufacture. Vox Sang 2013, 104:19-29.
27. Roche Molecular Systems, Inc. cobas® TaqScreen MPX® Test for use on the cobas® s201 System®. Product insert: 1636, Rev. 4. Indianapolis, IN: Roche; 2009.
28. Gen-Probe Inc. Procleix® Ultrio® Assay. Product insert: 502165, Rev. A. San Diego, CA: Gen-Probe Inc.; 2011.
29. Gen-Probe Inc. Procleix® Ultrio® Plus Assay. Product insert: 502932, Rev. 7. San Diego, CA: Gen-Probe Inc.; 2012.
30. Stramer S.L., Zou S., Notari E.P., Foster G.A., Krysztof D.E., Musavi F., et al. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?. Transfusion 2012, 52:440-446.
31. cobas® TaqScreen MPX® Test for use on the cobas® s201 System®. Roche; 2009. Available at: (accessed on 02/03/2014). http://www.fda.gov/UCM176443.pdf.
32. Longo M.C., Berninger M.S., Hartley J.L. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene 1990, 93:125-128.
33. Savva R., McAuley-Hecht K., Brown T., Pearl L. The structural basis of specific base-excision repair by uracil-DNA glycosylase. Nature 1995, 373:487-493.
34. Mol C.D., Arvai A.S., Slupphaug G., Kavli B., Alseth I., Krokan H.E., et al. Crystal structure and mutational analysis of human uracil-DNA glycosylase: structural basis for specificity and catalysis. Cell 1995, 80:869-878.
35. Higuchi R., Dollinger G., Walsh P.S., Shimosegawa T., Okamoto H. Simultaneous amplification and detection of specific DNA sequences. Biotechnology (N Y) 1992, 10:413-417.
36. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res 1996, 6:986-994.
37. cobas® TaqScreen MPX Test, v2.0 for use on the cobas® s 201 System. Rev. 1, 01/2011. Package insert. Branchburg, NJ: Roche Molecular Systems, Inc.; 2011.
38. Brojer E., Grabarczyk P., Liszewski G., Mikulska M., Allain J.P., Letowska M. Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Hepatology 2006, 44:1666-1674.
39. Li L., Chen P.J., Chen M.H., Chak K.F., Lin K.S., Tsai S.J. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus. Transfusion 2008, 48:1198-1206.
40. Dettori S., Candido A., Kondili L.A., Chionne P., Taffon S., Genovese D., et al. Identification of low HBV-DNA levels by nucleic acid amplification test (NAT) in blood donors. J Infect 2009, 59:128-133.
41. cobas® TaqScreen MPX® Test, for use on the cobas® s201 System®, Rev. 5, 01/2010. Package insert. Branchburg, NJ: Roche Molecular Systems, Inc.; 2010.
42. Assal A., Barlet V., Deschaseaux M., Dupont I., Gallian P., Guitton C., et al. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels. Transfusion 2009, 49:301-310.
43. Xiao X., Zhai J., Zeng J., Tian C., Wu H., Yu Y. Comparative evaluation of a triplex nucleic acid test for detection of HBV DNA, HCV RNA, and HIV-1 RNA, with the Procleix Tigris System. J Virol Methods 2013, 187:357-361.
44. McCormick M.K., Dockter J., Linnen J.M., Kolk D., Wu Y., Giachetti C. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA. J Clin Virol 2006, 36:166-176.
45. US Food and Drug Administration. Guidance for industry: Nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV): testing, product disposition, and donor deferral and reentry. US FDA; 2010. Available at: (accessed on 02/03/2014). http://www.fda.govqbiologicsbloodvaccinesqguidancecomplianceregulatoryinformation/Guidances/default.htm.
46. US Food and Drug Administration. Guidance for industry: use of nucleic acid tests on pooled and individual samples from donors of whole blood and blood components, including source plasma, to reduce the risk of transmission of hepatitis B virus. US FDA; 2012. Available at: (accessed on 02/03/2014). http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm.
47. Landers T.A., Greenberg H.B., Robinson W.S. Structure of hepatitis B Dane particle DNA and nature of the endogenous DNA polymerase reaction. J Virol 1977, 23:368-376.